title: Subcutaneous bortezomib: a step towards optimised drug use.
authors.affiliation: Haematology Department, University Hospital of Salamanca, Salamanca, Spain. mvmateos@usal.es
authors.forename: María-Victoria
authors.initials: MV
authors.lastname: Mateos
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001897:Boronic Acids / Q000008:administration & dosage* / Q000009:adverse effects*; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D009101:Multiple Myeloma / Q000188:drug therapy*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D011719:Pyrazines / Q000008:administration & dosage* / Q000009:adverse effects*; D011788:Quality of Life; D012008:Recurrence
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib